Page last updated: 2024-08-23

plicamycin and Neoplasms

plicamycin has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bond, GL; Hamir, A; Iwakuma, T; Jackson, JG; Johnson, DG; Levine, AJ; Lozano, G; Maccio, DR; Pant, V; Post, SM; Quintás-Cardama, A1
Blumenthal, SG; Dittmer, J; Lindemann, RK; Manns, J; Thomssen, C; Vetter, M; Wesselborg, S1

Other Studies

2 other study(ies) available for plicamycin and Neoplasms

ArticleYear
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.
    Cancer cell, 2010, Sep-14, Volume: 18, Issue:3

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Genes, p53; Genetic Predisposition to Disease; Humans; Mice; Neoplasms; Nuclear Proteins; Plicamycin; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Proto-Oncogene Proteins c-mdm2; RNA, Messenger; Signal Transduction; Sp1 Transcription Factor; Tumor Suppressor Protein p53

2010
Ets1 is an effector of protein kinase Calpha in cancer cells.
    Oncogene, 2005, Jan-20, Volume: 24, Issue:4

    Topics: Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cell Shape; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Oligonucleotide Array Sequence Analysis; Plicamycin; Protein Kinase C; Protein Kinase C-alpha; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; RNA Interference; Transcription Factors; Ultraviolet Rays

2005